These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 20111811

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A.
    An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
    [Abstract] [Full Text] [Related]

  • 3. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
    Gutiérrez J, Rodríguez M, Huber E, Muñoz A, Piédrola G, Maroto C.
    Microbios; 1996 May; 88(356):143-8. PubMed ID: 9141711
    [Abstract] [Full Text] [Related]

  • 4. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
    Sáenz González MC, Núñez Mateos JC, Rodrigo Sánchez N, Martín Sánchez AM.
    An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414
    [Abstract] [Full Text] [Related]

  • 5. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry.
    Ramondetti F, Sacco S, Comelli M, Bruno G, Falorni A, Iannilli A, d'Annunzio G, Iafusco D, Songini M, Toni S, Cherubini V, Carle F, RIDI Study Group.
    Diabet Med; 2012 Jun; 29(6):761-6. PubMed ID: 22133003
    [Abstract] [Full Text] [Related]

  • 6. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
    Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P.
    Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
    [Abstract] [Full Text] [Related]

  • 7. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
    Mossong J, Putz L, Schneider F.
    Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.
    Amela C, Pachón I, de Ory F.
    Eur J Epidemiol; 2003 Jan; 18(1):71-9. PubMed ID: 12705626
    [Abstract] [Full Text] [Related]

  • 10. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain].
    Suárez J, Castañeda MR, Gutiérrez CB, Rodríguez Barbosa JI, Tascón RI, Rodríguez Ferri EF.
    Med Clin (Barc); 1993 Oct 23; 101(13):484-7. PubMed ID: 8231381
    [Abstract] [Full Text] [Related]

  • 11. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
    Rodríguez ML, Martínez D, Santos-Sancho JM, Borda JR, Orero A.
    Rev Esp Quimioter; 2014 Jun 23; 27(2):98-101. PubMed ID: 24940889
    [Abstract] [Full Text] [Related]

  • 12. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.
    An Esp Pediatr; 1987 Jul 23; 27(1):27-31. PubMed ID: 3662251
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers].
    Oliveira J, da Cunha S, Côrte-Real R, Sampaio L, Dais N, Meliço-Silvestre A.
    Acta Med Port; 1995 Apr 23; 8(4):206-16. PubMed ID: 7625214
    [Abstract] [Full Text] [Related]

  • 15. Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study.
    Domínguez A, Plans P, Costa J, Torner N, Cardenosa N, Batalla J, Plasencia A, Salleras L.
    Eur J Clin Microbiol Infect Dis; 2006 May 23; 25(5):310-7. PubMed ID: 16786377
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 23; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 18. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 19. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 20. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M, Christenson B, Strandell A, Romanus V.
    Dev Biol Stand; 1986 Apr 25; 65():37-43. PubMed ID: 3556776
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.